{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:54:37Z","timestamp":1789512877336,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.adro.2018.07.009","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T13:26:33Z","timestamp":1533648393000},"page":"548-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Superficial radiation therapy in peyronie\u2019s disease: An effective and well-tolerated therapy"],"prefix":"10.1016","volume":"3","author":[{"given":"Gunilla","family":"Pietsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Anzeneder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Bruckbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zirbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gutermuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidelore","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"Biedermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Eberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2018.07.009_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/tau.2016.11.01","article-title":"Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction","volume":"6","author":"Campell","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.adro.2018.07.009_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: Results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2018.07.009_bib3","doi-asserted-by":"crossref","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","article-title":"The prevalence of Peyronie's disease in the United States: A population-based study","volume":"11","author":"Stuntz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2018.07.009_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1346-8138.12702","article-title":"Ionizing irradiation inhibits keloid fibroblast cell proliferation and induces premature cellular senescence","volume":"42","author":"Ji","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.adro.2018.07.009_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/tau.2016.03.15","article-title":"Injectable therapy for Peyronie's disease","volume":"5","author":"Chong","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.adro.2018.07.009_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5152\/tud.2016.40799","article-title":"Nonsurgical treatment options in Peyronie\u2019s disease: 2016 update","volume":"42","author":"Talib","year":"2016","journal-title":"Turk J Urol"},{"key":"10.1016\/j.adro.2018.07.009_bib7","article-title":"Collagenase clostridium histolyticum in the treatment of urologic disease: Current and future impact","volume":"25","author":"Gabrielson","year":"2017","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.adro.2018.07.009_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.21037\/tau.2016.03.24","article-title":"Oral therapy for Peyronie\u2019s disease, does it work?","volume":"5","author":"Barrett-Harlow","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.adro.2018.07.009_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11934-016-0622-2","article-title":"Peyronie's disease: Intralesional therapy and surgical intervention","volume":"17","author":"Aliperti","year":"2016","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.adro.2018.07.009_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie\u2019s disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2018.07.009_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-015-0818-2","article-title":"DEGRO guidelines for the radiotherapy of non-malignant disorders: Part III: Hyperproliferative disorders","volume":"191","author":"Seegenschmiedt","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2018.07.009_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00066-003-0984-5","article-title":"Strahlentherapie benigner Erkrankungen: Morbus Peyronie","volume":"179","author":"Meineke","year":"2003","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2018.07.009_bib13","doi-asserted-by":"crossref","first-page":"20150405","DOI":"10.1259\/bjr.20150405","article-title":"Radiotherapy for benign disease: Assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation","volume":"88","author":"McKeown","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2018.07.009_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijrobp.2005.06.009","article-title":"Results of radiotherapy for Peyronie's disease","volume":"64","author":"Niewald","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.07.009_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00066-003-1022-3","article-title":"Induratio penis plastica","volume":"179","author":"Pambor","year":"2003","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2018.07.009_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0090-4295(00)00805-0","article-title":"Current sexual functioning in 106 patients with Peyronie's disease treated with radiotherapy 9 years earlier","volume":"56","author":"Incrocci","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.adro.2018.07.009_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/18715281113129990055","article-title":"Clinical evaluation of natural history of Peyronie's disease: Our experience, old myths and new certainties","volume":"12","author":"Paulis","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.adro.2018.07.009_bib18","series-title":"Radiotherapy for Non-Malignant Disorders, Contemporary Concepts and Clinical Results","first-page":"193","article-title":"Peyronie's Disease","author":"Incrocci","year":"2008"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109418301301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109418301301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:37:02Z","timestamp":1762529822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109418301301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2452109418301301"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2018.07.009","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superficial radiation therapy in peyronie\u2019s disease: An effective and well-tolerated therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2018.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}